MeSH tree: C17.300.480
A study led by investigators from Johns Hopkins Medicine found that some patients with discoid lupus erythematosus—a form of skin lupus commonly diagnosed in young to middle-aged Black women that causes disk-shaped plaques ...
May 26, 2026
0
2
Ahead of World Lupus Day on May 10, new research from the Garvan Institute of Medical Research and UNSW Sydney helps explain why women are significantly more likely to be diagnosed with an autoimmune disease—a condition where ...
May 7, 2026
0
132
Chimeric antigen receptor (CAR) T-cell therapy is one of oncology's most powerful ideas: Harvest a cancer patient's own immune cells, genetically engineer them to recognize tumor cells, multiply them in a laboratory and reinject ...
Apr 29, 2026
0
9
Kidney damage is a serious complication affecting individuals with lupus, an autoimmune disease where immune B cells malfunction and produce antibodies that attack the body's own cells, tissues, and organs.
Apr 28, 2026
0
6
The body's immune reaction to increased levels of a toxic molecule, part of a bacterial species in the human gut, may reveal who is most at risk of developing lupus nephritis, according to a new study led by NYU Langone Health. ...
Apr 23, 2026
0
7
New research from Swansea University has identified significant delays and diagnostic barriers affecting rheumatology patients in Wales. The study is published in the Journal of Patient Experience.
Apr 17, 2026
0
6
Preeclampsia is a life-threatening pregnancy complication that affects roughly 1 in 10 pregnancies worldwide and, in the United States alone, around 5%–8% of pregnancies. The condition can lead to severe, long-term health ...
Apr 14, 2026
0
13
Skin, our largest organ, acts as a protective barrier against pathogens that try to invade our bodies while constantly monitoring for potential threats. In the skin's outermost layer, the epidermis, reside keratinocytes, ...
Johnson & Johnson's nipocalimab has been granted U.S. Food and Drug Administration Fast Track designation as a potential treatment for adults with systemic lupus erythematosus (SLE).
Mar 12, 2026
0
7
An already-approved IV drug significantly reduces the symptoms of lupus, a new clinical trial showed. More than three-quarters of lupus patients taking obinutuzumab (Gazvya) had a significant improvement in their symptoms ...
Mar 10, 2026
0
8
